RCS - Enviro Tech chemical - Introducing NUGEN(R) HLD-CD by Arxada

Lonza AGAnnouncement

24/04/2025 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250424:nRSX7495Fa&default-theme=true

RNS Number : 7495F  Enviro Tech Chemical Services, Inc.  24 April 2025

Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare
Disinfection

Delivering Effective Germ Control in Five Minutes

BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in
specialty chemicals and innovative solutions, announces the launch of NUGEN®
HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution
disinfects medical devices in just five minutes, ensuring that even the most
resilient microorganisms, which can withstand harsh conditions, are
destroyed.*

[related image]
(https://storage.googleapis.com/accesswire/featureimages/1018189/.jpg?v=0.33075787100544607)

NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare
environments. Its broad efficacy spectrum and short contact times make it
suitable for all critical areas, including operating rooms, isolation areas,
and intensive care units where speed and safety are essential.

"We are excited to introduce NUGEN® HLD-CD to the healthcare market," said
Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a
game-changer in disinfection technology for healthcare facilities, providing
professionals with a powerful means to improve patient safety and manage
infections more effectively."

The European Centre for Disease Prevention and Control reports that these
infections result in over 3.5 million cases each year in the EU and EEA,
causing more than 90,000 deaths. Effective infection control practices could
prevent up to 50% of healthcare-associated infections (HAIs).* NUGEN® HLD-CD
delivers powerful protection - arming frontline healthcare teams with a fast,
effective tool to stop infections before they spread.

Additionally, NUGEN® HLD-CD is an ideal solution for targeting Clostridium
difficile (C. diff) contamination*, a common and challenging pathogen in
healthcare settings that spreads via contact with contaminated surfaces.

For more information about NUGEN® HLD-CD and its applications, please
visit https://www.arxada.com/en/hygiene/hygiene-emea/nugen-hld-cd
(https://pr.report/9o8n)  or contact hygiene@arxada.com
(mailto:hygiene@arxada.com)

Media contacts:

Tricia Ryan

External Corporate Communications

Arxada
tricia.ryan@arxada.com (mailto:tricia.ryan@arxada.com)

Jane Smith

Marketing Communications, Professional Hygiene

Arxada
jane.smith@arxada.com (mailto:jane.smith@arxada.com)

About Arxada

Arxada is a global science-based specialty chemicals business creating
innovative chemistry and solutions. With customers in more than 100 countries,
it achieved sales of CHF 2.0 billion in 2023. The company aims to solve the
world's toughest preservation challenges by enhancing sustainability with
cleaner, greener solutions. Arxada focuses on multiple end-markets, primarily
in: Human Health & Nutrition, Home & Personal Care, Paints &
Coatings and Wood Protection, providing a broad portfolio of differentiated
products and solutions, supported by its and innovation capabilities, in-depth
regulatory know-how and track record in manufacturing and process development.
Headquartered in Basel (Switzerland), the company's 3,400 employees contribute
to the success of its customers, spanning 24 production sites and 14 R&D
centers. To learn more about Arxada, please visit: www.arxada.com and Arxada
on LinkedIn.

This product is intended for use as a medical device within the European Union
and is sold exclusively to healthcare professionals. It has undergone a
conformity assessment to ensure compliance with EU regulations, including the
Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. The
product is designed to meet the highest standards of safety and performance.
Users are advised to follow the instructions for use provided by the
manufacturer. The manufacturer is not liable for any misuse or off-label use
of the product. All trademarks belong to Arxada or its affiliates. © 2025
Arxada.

*Data on file with Arxada; based on internal and external testing

SOURCE: Enviro Tech Chemical Services, Inc.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAGZGZDRZKGKZM